# Quantum annealing for enhanced feature selection in single-cell RNA sequencing data analysis

**Authors:** Selim Romero, Shreyan Gupta, Victoria Gatlin, Robert S. Chapkin, James J. Cai

PMC · DOI: 10.1007/s42484-025-00312-1 · Quantum machine intelligence · 2026-03-25

## TL;DR

This paper explores using quantum computing to improve gene selection in single-cell RNA sequencing data, helping uncover important biological patterns.

## Contribution

The paper introduces quantum annealing-based QUBO for feature selection in scRNA-seq data, offering a novel computational approach.

## Key findings

- QUBO identifies genes with expression patterns linked to cell state transitions and drug resistance.
- Quantum annealing reveals complex gene patterns missed by traditional methods.
- The approach enhances interpretation of scRNA-seq data in differentiation and drug resistance studies.

## Abstract

Feature selection is a machine learning technique for identifying relevant variables in classification and regression models. In single-cell RNA sequencing (scRNA-seq) data analysis, feature selection is used to identify relevant genes that are crucial for understanding cellular processes. Traditional feature selection methods often struggle with the complexity of scRNA-seq data and suffer from interpretation difficulties. Quantum annealing presents a promising alternative approach. In this study, we implement quantum annealing-empowered quadratic unconstrained binary optimization (QUBO) for feature selection in scRNA-seq data. Using data from a human cell differentiation system and an anticancer drug resistance study, we demonstrate that QUBO feature selection effectively identifies genes whose expression patterns reflect critical cell state transitions associated with differentiation and drug resistance development. Our findings indicate that quantum annealing-powered QUBO reveals complex gene expression patterns potentially missed by traditional methods, thereby enhancing scRNA-seq data analysis and interpretation.

## Full-text entities

- **Genes:** NAP1L1 (nucleosome assembly protein 1 like 1) [NCBI Gene 4673] {aka NAP1, NAP1L, NRP}, SPCS3 (signal peptidase complex subunit 3) [NCBI Gene 60559] {aka PRO3567, SPC22, SPC22/23, SPC23, SPC3, YLR066W}, PCAT14 (prostate cancer associated transcript 14) [NCBI Gene 101978785], POMP (proteasome maturation protein) [NCBI Gene 51371] {aka C13orf12, HSPC014, PNAS-110, PRAAS2, UMP1}, ANP32E (acidic nuclear phosphoprotein 32 family member E) [NCBI Gene 81611] {aka LANP-L, LANPL}, RGS10 (regulator of G protein signaling 10) [NCBI Gene 6001], RAMP2 (receptor activity modifying protein 2) [NCBI Gene 10266], KLK10 (kallikrein related peptidase 10) [NCBI Gene 5655] {aka NES1, PRSSL1}, TUBA1C (tubulin alpha 1c) [NCBI Gene 84790] {aka OZEMA24, TUBA6, bcm948}, ADM (adrenomedullin) [NCBI Gene 133] {aka AM, PAMP}, GPR166P (G protein-coupled receptor 166, pseudogene) [NCBI Gene 442206] {aka GPCR, PGR9}, PRRT2 (proline rich transmembrane protein 2) [NCBI Gene 112476] {aka BFIC2, BFIS2, DSPB3, DYT10, EKD1, FICCA}, ID1 (inhibitor of DNA binding 1) [NCBI Gene 3397] {aka ID, bHLHb24}, PRR13 (proline rich 13) [NCBI Gene 54458] {aka TXR1}, FLI1 (Fli-1 proto-oncogene, ETS transcription factor) [NCBI Gene 2313] {aka BDPLT21, EWSR2, FLI-1, SIC-1}, DTL (denticleless E3 ubiquitin protein ligase adapter) [NCBI Gene 51514] {aka CDT2, DCAF2, L2DTL, RAMP}, FABP5 (fatty acid binding protein 5) [NCBI Gene 2171] {aka E-FABP, EFABP, KFABP, PA-FABP, PAFABP}, CCND1 (cyclin D1) [NCBI Gene 595] {aka BCL1, D11S287E, PRAD1, U21B31}, DPYSL2 (dihydropyrimidinase like 2) [NCBI Gene 1808] {aka CRMP-2, CRMP2, DHPRP2, DRP-2, DRP2, N2A3}, GDF15 (growth differentiation factor 15) [NCBI Gene 9518] {aka GDF-15, HG, MIC-1, MIC1, NAG-1, PDF}, BIRC5 (baculoviral IAP repeat containing 5) [NCBI Gene 332] {aka API4, EPR-1}, OAZ1 (ornithine decarboxylase antizyme 1) [NCBI Gene 4946] {aka AZ1, AZI, OAZ}, IGFBP5 (insulin like growth factor binding protein 5) [NCBI Gene 3488] {aka IBP5}, STMN1 (stathmin 1) [NCBI Gene 3925] {aka C1orf215, LAP18, Lag, OP18, PP17, PP19}, XRCC5 (X-ray repair cross complementing 5) [NCBI Gene 7520] {aka KARP-1, KARP1, KU80, KUB2, Ku86, NFIV}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, APLN (apelin) [NCBI Gene 8862] {aka APEL, XNPEP2}, DRAP1 (DR1 associated protein 1) [NCBI Gene 10589] {aka NC2-alpha}, ATF5 (activating transcription factor 5) [NCBI Gene 22809] {aka ATFX, HMFN0395}, KRT10 (keratin 10) [NCBI Gene 3858] {aka BCIE, BIE, CK10, EHK, EHK2, EHK2A}, CD81 (CD81 molecule) [NCBI Gene 975] {aka CVID6, S5.7, TAPA1, TSPAN28}, ID3 (inhibitor of DNA binding 3) [NCBI Gene 3399] {aka HEIR-1, bHLHb25}, ACTR2 (actin related protein 2) [NCBI Gene 10097] {aka ARP2}, TP53I11 (tumor protein p53 inducible protein 11) [NCBI Gene 9537] {aka PIG11}, TRH (thyrotropin releasing hormone) [NCBI Gene 7200] {aka Pro-TRH, TRF}, VIM (vimentin) [NCBI Gene 7431], MAP1B (microtubule associated protein 1B) [NCBI Gene 4131] {aka DFNA83, FUTSCH, MAP5, PPP1R102, PVNH9}, GSTK1 (glutathione S-transferase kappa 1) [NCBI Gene 373156] {aka GST, GST 13-13, GST13, GST13-13, GSTK1-1, hGSTK1}, GNG5 (G protein subunit gamma 5) [NCBI Gene 2787], EPHA1 (EPH receptor A1) [NCBI Gene 2041] {aka EPH, EPHT, EPHT1}, CLDN7 (claudin 7) [NCBI Gene 1366] {aka CEPTRL2, CLDN-7, CPETRL2, Hs.84359, claudin-1}, SFRP1 (secreted frizzled related protein 1) [NCBI Gene 6422] {aka FRP, FRP-1, FRP1, FrzA, SARP2}, IER2 (immediate early response 2) [NCBI Gene 9592] {aka CHX1, ETR101}, LITAF (lipopolysaccharide induced TNF factor) [NCBI Gene 9516] {aka PIG7, SIMPLE, TP53I7}, HMGB3 (high mobility group box 3) [NCBI Gene 3149] {aka HMG-2a, HMG-4, HMG2A, HMG4}, HMGN1 (high mobility group nucleosome binding domain 1) [NCBI Gene 3150] {aka HMG14}, TPM3 (tropomyosin 3) [NCBI Gene 7170] {aka CAPM1, CFTD, CMYO4A, CMYO4B, CMYP4A, CMYP4B}, ARPC3 (actin related protein 2/3 complex subunit 3) [NCBI Gene 10094] {aka ARC21, p21-Arc}, PDAP1 (PDGFA associated protein 1) [NCBI Gene 11333] {aka HASPP28, PAP, PAP1}, CALCRL (calcitonin receptor like receptor) [NCBI Gene 10203] {aka CGRPR, CRLR, LMPHM8}, ANLN (anillin, actin binding protein) [NCBI Gene 54443] {aka FSGS8, Scraps, scra}, ALDH3A1 (aldehyde dehydrogenase 3 family member A1) [NCBI Gene 218] {aka ALDH3, ALDHIII}, EIF4EBP1 (eukaryotic translation initiation factor 4E binding protein 1) [NCBI Gene 1978] {aka 4E-BP1, 4EBP1, BP-1, PHAS-I}, BEX1 (brain expressed X-linked 1) [NCBI Gene 55859] {aka BEX2, HBEX2, HGR74-h}, TMA7 (translation machinery associated 7 homolog) [NCBI Gene 51372] {aka CCDC72, HSPC016}, DYNLT1 (dynein light chain Tctex-type 1) [NCBI Gene 6993] {aka CW-1, TCTEL1, TCTEX1, tctex-1}, RPS19BP1 (ribosomal protein S19 binding protein 1) [NCBI Gene 91582] {aka AROS, S19BP}, EIF2S2 (eukaryotic translation initiation factor 2 subunit beta) [NCBI Gene 8894] {aka EIF2, EIF2B, EIF2beta, PPP1R67, eIF-2-beta}, MYL12B (myosin light chain 12B) [NCBI Gene 103910] {aka MLC-B, MRLC2}, THY1 (Thy-1 cell surface antigen) [NCBI Gene 7070] {aka CD90, CDw90}
- **Diseases:** non-small cell lung carcinoma (MESH:D002289), EC (MESH:D005955), lung cancer (MESH:D008175), cancer (MESH:D009369)
- **Chemicals:** aromatic amino acid (MESH:D024322), erlotinib (MESH:D000069347), PHATE (-), paclitaxel (MESH:D017239)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** PC9 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_B260), hESCs — Homo sapiens (Human), Embryonic stem cell (CVCL_UI95)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13012334/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13012334/full.md

## References

40 references — full list in the complete paper: https://tomesphere.com/paper/PMC13012334/full.md

---
Source: https://tomesphere.com/paper/PMC13012334